Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer

Long-term influence of oestrogen plus progestin vs oestrogen alone on breast cancer incidence in post-menopausal women

Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer

Circulating tumour DNA used to predict disease recurrence for early triple-negative breast cancer

Oral paclitaxel with encequidar in metastatic breast cancer

Pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembrolizumab in TNBC patients

Combining atezolizumab to neoadjuvant chemotherapy does not improve pathologic complete response rates for TNBC patients

Breast cancer prevention in high-risk post-menopausal women

Accelerated partial breast irradiation versus whole breast irradiation in patients with early breast cancer

Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of triple-negative breast cancer

Preventative effects of anastrozole in post-menopausal women who are at high-risk for developing breast cancer

How effective is accelerated partial breast irradiation in patients with early breast cancer?